EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Hidradenitis Suppurativa: A Review of the Biologic and Small Molecule Immunomodulatory Treatments

Nicholas Chiang iD, Raed Alhusayen

Journal of Cutaneous Medicine and Surgery · 2025

DOI: 10.1177/12034754241300292 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Cutaneous Medicine and Surgery, 2025. Verfasst von Nicholas Chiang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada. Hauptthemen laut MEDLINE: Hidradenitis Suppurativa, Immunomodulating Agents, Immunologic Factors, Biological Products. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 157 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease that presents as painful, deep-seated nodules, sinus tracts, and abscesses in about 1% of the population. Although the pathogenesis of HS is not perfectly understood, it is generally recognized to be caused by a combination of genetic, endocrine, environmental, and microbiological factors. The treatment principles of HS focus on decreasing the microbial load with antibiotics and/or modulating the host immune response to reduce inflammation. The treatment of adults with moderate-to-severe HS has significantly changed recently with the development of new biological medications and immunomodulators. While previously the mainstay of treatment of moderate-to-severe HS was adalimumab, a biologic tumour necrosis factor α inhibitor, the evidence for the use of other treatment classes such as interleukin (IL)-17 inhibitors, IL-1 inhibitors, and Janus kinase inhibitors has been growing. The goal of this review article is to review the available evidence that supports the efficacy and safety of biologics and small molecule immunomodulator treatments to treat adults with moderate-to-severe HS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hidradenitis SuppurativaImmunomodulating AgentsImmunologic FactorsBiological ProductsHumansAdalimumabTumor Necrosis Factor-alphaInterleukin-17

Stichwörter der Autor:innen

biologichidradenitis suppurativaimmunomodulator

Substanzen

Immunomodulating AgentsImmunologic FactorsBiological ProductsAdalimumabTumor Necrosis Factor-alphaInterleukin-17

Autor:innen und Institutionen

  • Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
  • Department of Dermatology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.

ORCID-Profile: Nicholas Chiang

Zitieren

APA

Chiang, N., & Alhusayen, R. (2025). Hidradenitis Suppurativa: A Review of the Biologic and Small Molecule Immunomodulatory Treatments. Journal of Cutaneous Medicine and Surgery. https://doi.org/10.1177/12034754241300292

Vancouver

Chiang N, Alhusayen R. Hidradenitis Suppurativa: A Review of the Biologic and Small Molecule Immunomodulatory Treatments. Journal of Cutaneous Medicine and Surgery. 2025. doi:10.1177/12034754241300292

BibTeX
@article{Chiang2025,
  author = {Chiang, Nicholas and Alhusayen, Raed},
  title = {Hidradenitis Suppurativa: A Review of the Biologic and Small Molecule Immunomodulatory Treatments},
  journal = {Journal of Cutaneous Medicine and Surgery},
  year = {2025},
  doi = {10.1177/12034754241300292}
}
Kostenlos starten →